Ownership and insider activity for McKesson Corporation (MCK): recent transactions by executives and directors. Track how corporate insiders are trading the stock.
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S.
Price
| Price | $994.58 (closing price, October 30, 2026) |
| Market Cap | $116.0B |
| Exchange | NYSE |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-10-15 | Fraga Francisco | S-Sale | 800 | $797K |
| 2026-09-08 | Rutledge Napoleon B JR | S-Sale | 111 | $99K |
| 2026-08-07 | Srinivasan Ramesh (NMN) | A-Award | 368 | |
| 2026-08-10 | Lerman Bradley E | S-Sale | 301 | $269K |
| 2026-08-01 | Srinivasan Ramesh (NMN) | |||
| 2026-08-01 | Srinivasan Ramesh (NMN) | 316 | ||
| 2026-07-22 | Hinton James H. | A-Award | 277 | |
| 2026-07-22 | Doughtie Lynne M | A-Award | 277 | |
| 2026-07-22 | Wilson-Thompson Kathleen | A-Award | 277 | $225K |
| 2026-07-22 | Dunbar Webster Roy | A-Award | 277 |
Balance Sheet (10y)
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.78B | $2.67B | $2.98B | $4.01B | $6.28B | $3.53B | $4.68B | $4.58B | $5.69B | $3.98B |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $18.21B | $17.71B | $18.25B | $19.95B | $19.18B | $18.58B | $19.41B | $21.62B | $25.64B | $27.98B |
| Inventory | $15.28B | $16.31B | $16.71B | $16.73B | $19.25B | $18.70B | $19.69B | $21.14B | $23.00B | $24.21B |
| Total Current Assets | $36.95B | $37.14B | $38.47B | $42.22B | $45.38B | $46.23B | $44.29B | $47.97B | $55.40B | $57.21B |
| Property, Plant & Equipment | $2.29B | $2.46B | $2.55B | $4.25B | $4.68B | $3.64B | $3.81B | $4.04B | $4.28B | $4.73B |
| Goodwill | $10.59B | $10.92B | $9.36B | $9.36B | $9.49B | $9.45B | $9.95B | $10.13B | $10.02B | $11.32B |
| Intangible Assets | $3.67B | $4.10B | $3.69B | $3.16B | $2.88B | $2.06B | $2.28B | $2.11B | $1.46B | $4.08B |
| Total Assets | $60.97B | $60.38B | $59.67B | $61.25B | $65.02B | $63.30B | $62.32B | $67.44B | $75.14B | $82.32B |
| Accounts Payable | $31.02B | $32.18B | $33.85B | $37.20B | $38.98B | $38.09B | $42.49B | $47.10B | $55.33B | $59.97B |
| Short-term Debt | $1.24B | $1.13B | $330.0M | $1.05B | $742.0M | $799.0M | $968.0M | $50.0M | $1.19B | $1.27B |
| Total Current Liabilities | $35.61B | $36.69B | $37.63B | $42.62B | $44.10B | $48.47B | $47.96B | $52.36B | $61.60B | $67.02B |
| Long-term Debt | $7.30B | $6.75B | $7.26B | $6.33B | $6.41B | $5.08B | $4.63B | $5.58B | $4.46B | $5.11B |
| Total Liabilities | $48.37B | $48.87B | $49.99B | $54.54B | $63.57B | $65.09B | $63.81B | $69.04B | $76.83B | $83.16B |
| Retained Earnings | $13.19B | $12.99B | $12.41B | $13.02B | $8.20B | $9.03B | $12.29B | $14.98B | $17.92B | $22.29B |
| Total Equity | $11.10B | $9.80B | $8.09B | $5.09B | -$21.0M | -$2.27B | -$1.86B | -$1.97B | -$2.07B | -$2.17B |
| Total Debt | $8.54B | $7.88B | $7.59B | $9.40B | $9.40B | $7.54B | $7.29B | $7.39B | $7.39B | $8.61B |
| Net Debt | $5.76B | $5.21B | $4.61B | $5.39B | $3.13B | $4.01B | $2.62B | $2.81B | $1.70B | $4.64B |
| Working Capital | $1.34B | $451.0M | $839.0M | -$402.0M | $1.28B | -$2.23B | -$3.67B | -$4.39B | -$6.21B | -$9.81B |
Financial Health
| Debt / Equity | -2.76 |
| Current Ratio | 0.89 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 6.17 |
Profitability
| Return on Equity | -194.39% |
| Return on Invested Capital | 27.91% |
| Return on Assets | 5.20% |
| Gross Margin | 3.64% |
| Operating Margin | 1.62% |
| Net Margin | 1.12% |
Related companies: COR · CAH · 0JZU.L · 0HF3.L · 0HTG.L · HSIC · 0L3C.L
Explore sector: Healthcare · Medical - Distribution
More sections of MCK: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks